Clinical development of a stable glucagon formulation for BI-hormonal pump
Ended Project Grant Awarded Last action
- Award ID
- R44DK096706
- Recipient
-
Xeris Pharmaceuticals, Inc. UEI YAV5AK7VKJ31
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,056,857
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Austin, TX 78759, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $713,733 | |
| Amendment | $6,331 | |
| Original award | $336,793 |
Quick answers
Who received award R44DK096706?
R44DK096706 was awarded to Xeris Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on August 1, 2012.
How much is award R44DK096706 worth?
$1,056,857 has been obligated on R44DK096706.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award